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Abstract
Rationale Due to its intrinsic deficiency in prepulse
inhibition (PPI), the inbred DBA/2 mouse strain has been
considered as an animal model for evaluating antipsychotic
drugs. However, the PPI impairment observed in DBA/2
mice relative to the common C57BL/6 strain is confounded
by a concomitant reduction in baseline startle reactivity. In
this study, we examined the robustness of the PPI deficit
when this confound is fully taken into account.
Materials and methods Male DBA/2 and C57BL/6 mice
were compared in a PPI experiment using multiple pulse
stimulus intensities, allowing the possible matching of
startle reactivity prior to examination of PPI. The known
PPI-enhancing effect of the antipsychotic, clozapine, was
then evaluated in half of the animals, whilst the other half
was subjected to two additional schizophrenia-relevant
behavioural tests: latent inhibition (LI) and locomotor
reaction to the psychostimulants—amphetamine and
phencyclidine.
Results PPI deficiency in DBA/2 relative to C57BL/6 mice
was essentially independent of the strain difference in
baseline startle reactivity. Yet, there was no evidence that
DBA/2 mice were superior in detecting the PPI-facilitating
effect of clozapine when startle difference was balanced.
Compared with C57BL/6 mice, DBA/2 mice also showed
impaired LI and a different temporal profile in their
responses to amphetamine and phencyclidine.
Conclusion Relative to the C57BL/6 strain, DBA/2 mice
displayed multiple behavioural traits relevant to schizophrenia
psycho- and physiopathology, indicative of both dopaminer-
gic and glutamatergic/N-methyl-D-aspartic acid receptor
dysfunctions. Further examination of their underlying neu-
robiological differences is therefore warranted in order to
enhance the power of this specific inter-strain comparison as
a model of schizophrenia.
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Introduction
Behavioural phenotypic divergence between strains of
laboratory rodents is relevant to behavioural genetics and
provides an opportunity to develop animal models of
specific psychopathological traits. One approach is to
develop selective breeding (e.g. Logue et al. 1997;
McCaughran et al. 1997; Schwabe et al. 2007), whilst
another is to compare existing, usually inbred strains with
relatively stable genetic backgrounds (Bullock et al. 1997;
Crawley et al. 1997; Paylor and Crawley 1997). The inbred
DBA/2 mouse strain has attracted interests recently in its
potential relevance to psychosis-related traits in comparison
to another common inbred mouse strain—the C57BL/6
strain—as the reference line (Olivier et al. 2001; Spielewoy
and Markou 2004). DBA is the oldest recorded inbred
mouse strain originating from Little in 1909, and substrains
DBA/1 and DBA/2 were established in 1929–1930, both of
which are now maintained in the Jackson Laboratory (see
Mouse Genome Informatics at http://www.informatics.jax.
org/external/festing/mouse/docs/DBA.shtml). Since the
1960s, strain comparison studies have reported various
notable behavioural phenotypes in the DBA/2 substrain,
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as catalogued in the Mouse Genome Informatics database
(see link above). A number of cognitive traits revealed in
DBA/2 mice, such as spatial memory deficits, have led to
the suggestion that they may represent a model of
hippocampal dysfunction (Ammassari-Teule et al. 1995;
Paylor et al. 1993).
Of particular relevance to psychotic traits is the
consistent reporting of weak prepulse inhibition (PPI)
expression and related physiological gating in DBA/2 mice
(e.g. Bortolato et al. 2007; Bullock et al. 1997; Logue et al.
1997; McCaughran et al. 1997; Olivier et al. 2001; Stevens
et al. 1996; Stevens and Wear 1997). PPI represents a form
of sensorimotor gating that is deficient in schizophrenia
patients, and it can be readily demonstrated in humans as
well as in animals using the ubiquitous acoustic startle
reflex (Hoffman and Searle 1965). PPI is commonly
demonstrated by the reduction in the startle reaction to a
loud pulse stimulus when it is shortly preceded by a brief,
non-startling prepulse stimulus. It is therefore a powerful
translational paradigm for dysfunction in pre-attentive
information processing and sensorimotor gating which
exists in various psychiatric disorders, including schizo-
phrenia (Braff et al. 2001; Csomor et al. 2009; Geyer et al.
2002; Swerdlow and Geyer 1998; Swerdlow et al. 2008). A
number of comparative studies between inbred mouse
strains have revealed considerable divergence in PPI
expression (e.g. Bullock et al. 1997; Geyer et al. 2002;
Logue et al. 1997; McCaughran et al. 1997; Paylor and
Crawley 1997) and led to the suggestion that mouse strains
with low basal levels of PPI may be useful in studying the
neural basis of PPI deficiency without the requirement of
additional pharmacological interventions to induce a PPI
deficit (see McCaughran et al. 1997). Olivier et al. (2001)
further proposed more specifically that the weak PPI
phenotype observed in the DBA/2 substrain (relative to
other mouse strains) may serve as a model to screen for
antipsychotic drugs—a recommendation that has been
adopted in a number of recent psychopharmacological
studies of novel antipsychotics, including histamine H3
receptor antagonists (Browman et al. 2004; Fox et al. 2005)
and glycine transporter 1 inhibitors (Boulay et al. 2008;
Depoortère et al. 2005; Kinney et al. 2003).
However, past studies have largely overlooked the
concomitant change in startle reaction magnitude. In
DBA/2 mice, the reported PPI deficits are confounded by
a pronounced reduction in startle reaction (e.g. Bortolato et
al. 2007; Crawley et al. 1997; McCaughran et al. 1997;
Paylor and Crawley 1997). This is of significant concern
because differences in the baseline startle reactivity can
seriously complicate or confound the interpretation of the
results obtained on PPI (Csomor et al. 2006, 2008;
Hoffman and Searle 1965; Swerdlow et al. 2000; Yee et
al. 2005). The dependency of PPI magnitude on baseline
startle reactivity has been demonstrated in rodents and
humans (Csomor et al. 2006, 2008; Hince and Martin-
Iverson 2005; Yee et al. 2005)—a finding that has been
incorporated also by computational models of PPI (Sandner
and Canal 2007; Schmajuk and Larrauri 2005). The present
study was undertaken to initially address the confounding
phenotype on startle reactivity in comparison with C57BL/6
mice using a more stringent parametric design of PPI
assessment incorporating multiple pulse intensities (Csomor
et al. 2006, 2008; Yee et al. 2005). With this PPI design, we
went on to investigate if the DBA/2 substrain may enjoy
superior sensitivity (compared with C57BL/6 mice) in the
detection of atypical neuroleptic drugs using clozapine as the
reference compound.
The present study also includes comparisons between
DBA/2 and C57BL/6 mice in another behavioural paradigm
of psychosis-related attentional deficits, namely latent
inhibition (LI). Unlike PPI, LI refers to a form of learned
attentional control by which repeated exposures to an
inconsequential stimulus lead to a loss of associability of
the stimulus, as shown by its weakened ability to enter into
association with other significant stimuli in Pavlovian and
instrumental conditioning paradigms (Lubow and Moore
1959). LI is also deficient in some subsets of schizophrenia
patients (e.g. Baruch et al. 1988; Gray et al. 1992; Williams
et al. 1998), and it has been suggested that a distinction
between pathological traits associated with positive and
negative symptoms of schizophrenia can be achieved by
appropriate parametric variation of the LI paradigm (see
Weiner 2003). Such manipulation was included here, thus
allowing an important extension to previous studies of LI
expression in DBA/2 mice (Baarendse et al. 2008; Gould
and Wehner 1999; Restivo et al. 2002). Finally, we also
evaluated in the comparison between DBA/2 and C57BL/6
mice whether the former would exhibit pharmacologically
induced phenotypes that are in keeping with the dopamine
and glutamate/N-methyl-D-aspartic acid (NMDA) hypothe-
ses of schizophrenia (c.f. Coyle 2006; Carlsson 1988; Javitt
2007; Snyder 1976). To this end, the animals were
subjected to acute challenge either of an indirect dopamine
receptor agonist, amphetamine, or the non-competitive
NMDA receptor antagonist, phencyclidine (PCP).
Materials and methods
Subjects
Adult male C57BL/6 (n=36) and DBA/2 (n=40) mice were
obtained from the Charles River Laboratories (Germany).
They were kept in groups of four to five in Makrolon® type
III cages (Techniplast, Milan, Italy) and housed in an
animal vivarium under a reversed 12/12-h light–dark cycle
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(lights on 2000–0800 hours) with ad lib food and water
throughout the entire experimental period. The mice were
acclimatised to the laboratory housing conditions for
2 weeks before the commencement of behavioural testing
at an age of approximately 12 weeks. The tests were all
conducted in the dark phase of the light–dark cycle. All
procedures performed on the animals had been approved by
the Zurich Cantonal Veterinary Office, in accordance with
the Animal Protection Act of Switzerland (1978), the
European Council Directives 86/609/EEC on animal exper-
imentation and the Principles of Laboratory Animal Care
(NIH publication no. 86-23, revised 1985).
Overall experimental design
First of all, in experiment 1, PPI was evaluated in all the
animals, after which they were subdivided into two balanced
cohorts in terms of mean startle reactivity and PPI expres-
sion. One cohort then was subjected to another PPI
experiment in which the efficacy of clozapine to modify
PPI expression was examined with a 2×2 (strain × drug)
factorial design (experiment 2; n=9 or 10 per cell). From the
second cohort, 16 DBA/2 mice and 16 C57BL/6 mice were
randomly selected and further subdivided for two separate
LI experiments, each using a different number of stimulus
pre-exposures (experiments 3A and 3B; n=4 per cell). Due
to time limitations (for the experiments to be completed in
2 days) and the availability of just four shuttle boxes,
experiments 3A and 3B together were carried out with only
32 out of the available 38 animals. Following the completion
of experiment 3, the animals were evaluated in locomotor
reaction to amphetamine or PCP in comparison with saline
vehicle treatment (experiment 4; n=5 or 6 per cell). The
overall experimental plan including sequence, duration of
each test, number of rest days between tests and the number
of subjects are summarised in Fig. 1.
Prepulse inhibition of the acoustic startle reflex
Apparatus The apparatus consisted of four acoustic startle
chambers for mice (SR-LAB, San Diego Instruments, San
Diego, CA, USA) each containing a non-restrictive clear
Plexiglas cylindrical enclosure attached to a horizontal
mobile platform, which, in turn, rested on a solid base
inside a sound-attenuated isolation cubicle. A high-
frequency loudspeaker, mounted directly above the animal
enclosure inside each cubicle, produced a continuous
background noise of 65 dBA, together with the various
acoustic stimuli in the form of white noise. The forces
acting on the Plexiglas enclosure caused by the whole-body
startle response of the animal were converted into analogue
signals by a piezoelectric unit attached to the platform.
These signals were digitised and stored by a computer. A
total of 130 readings were taken at 0.5-ms intervals (i.e.
spanning 65 ms), starting at the onset of the startle stimulus
in pulse-alone and prepulse-plus-pulse trials and at the
onset of the prepulse stimulus in prepulse-alone trials. The
average amplitude over the 65 ms was used to determine
the stimulus reactivity. The sensitivity of the stabilimeter
was routinely calibrated to ensure consistency between
chambers and across sessions.
Procedures Here, we adopted the procedures and testing
parameters developed by Yee et al. (2005). PPI was
assessed in a test session lasting for approximately 40 min
in which the subjects were presented with a series of
discrete trials comprising a mixture of four types of trial.
These included pulse-alone trials, prepulse-plus-pulse trials,
prepulse-alone trials and trials in which no discrete
stimulus, other than the constant background noise, was
presented (“no-stimulus” trials). A reduction of startle
magnitude in prepulse-plus-pulse trials relative to that in
pulse-alone trials (of the same pulse intensity) constitutes
PPI. Pulse stimuli of 40-ms duration and of three different
intensities were employed: 100, 110 and 120 dBA. Prepulse
stimuli of 20-ms duration were employed with three
different intensities: 71, 77 and 83 dBA (corresponding to
6, 12 and 18 decibel units above background, respectively).
In the prepulse-plus-pulse trials, a stimulus onset asynchro-
ny of 100 ms was used.
A session began when the animals were placed into the
Plexiglas enclosure. They were acclimatised to the appara-
tus for 2 min and then presented with three blocks of trials.
The first block comprised six pulse-alone trials: two trials
of each of the three possible pulse intensities. These trials
served to habituate and stabilise the animals' startle
response and were analysed separately. In the intermediate
block, the animals were presented with ten series of discrete
test trials. Each series consisted of the following trials: three
pulse-alone trials (100, 110 or 120 dBA), three prepulse-
alone trials (+6, +12 or +18 decibel units above background)
and nine possible combinations of prepulse-plus-pulse trials
(three levels of prepulse × three levels of pulse) and one no-
stimulus (or background alone) trial. The 16 discrete trials
within each series were presented in a pseudorandom order,
with a variable inter-trial interval of a mean of 15 s (ranging
from 10 to 20 s). The session was concluded with a final
block of six consecutive pulse-alone trials as in the first
block.
Drug administration In experiment 2 (see Fig. 1), the
animals were administered with either clozapine or vehicle
solution 45 min prior to PPI testing. Allocation of subjects
to drug conditions was counterbalanced with respect to
baseline PPI and startle reactivity scores obtained in
experiment 1. Thus, the repeated use of animals from
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experiments 1 to 2 offered a distinct advantage. The
replication of the baseline difference in PPI expression
between strains in experiment 2 (see later) confirmed that
the results obtained in experiment 2 were unlikely to be
biased by the repeated use of the same animals as such.
Clozapine (obtained from Sigma-Aldrich, Germany) was
dissolved in 0.1 N HCl in physiological saline solution and
then neutralised to pH5.5 with Na2CO3 to achieve the
desired dose of 1 mg/kg. For the vehicle treatment,
physiological saline/lactic acid (pH5.5) was prepared. All
substances were freshly prepared on the day of injection
and administered in a volume of 5 ml/kg body weight via
the intraperitoneal route (i.p.).
Latent inhibition in two-way active avoidance learning
Apparatus The apparatus comprised four identical two-way
shuttle boxes (model H10-11M-SC; Coulbourn Instru-
ments) each housed within a sound-attenuating chest, as
described fully elsewhere (Chang et al. 2007; Yee et al.
2006). With internal dimensions of 35.5×17×21.5 cm, each
box was divided into two identical compartments by an
aluminium wall with an interconnecting opening (6.77×
7.7 cm), allowing free movement of the animal from one
compartment to the other (i.e. a shuttle response). The grid
floor was made of stainless steel rods (diameter, 0.4 cm;
spaced at 0.7 cm centre-to-centre) through which electric
shocks (0.3 mA) generated by a shock module (model H10-
1M-XX-SF; Coulbourn Instruments) could be delivered.
The conditioned stimulus (CS) was an 85 dBA white noise
generated by a tone module (model E12-02; Coulbourn
Instruments) mounted behind the shuttle box. Shuttle
response was detected by a series of photocells (H20-
95X; Coulbourn Instruments) mounted on the sides of both
compartments. The boxes were illuminated during the entire
experimental session by two diffused light sources (1.1 W),
one mounted on the end wall of each compartment 19 cm
above the grid floor. Background noise was provided by a
ventilation fan mounted at the back of each shuttle box.
Procedures Weiner (2003) emphasises that abnormality in
LI may assume the form of an attenuation (against the
presence of strong LI in controls) or abnormal persistence
(against the absence of LI in controls). It would be
necessary to examine both these possibilities. Here, we
manipulated the magnitude of LI in the C57BL/6 group by
varying the number of stimulus pre-exposures. With 100
stimulus pre-exposures, robust LI was obtained in C57BL/6
mice, whilst 50 pre-exposures yielded no significant LI in
this strain of mice in two-way active avoidance (P. Singer,
W-N. Zhang, J. Feldon and B.K. Yee, unpublished data).
Otherwise, the procedures for the two experiments were
identical and followed a 2×2 factorial design with the
between-subjects factors: strain (DBA/2 vs. C57BL/6) and
pre-exposure (PE vs. nPE). These factors were counter-
balanced across the four shuttle boxes. Each experiment
comprised two phases, pre-exposure and conditioning,
conducted 24 h apart.
On the pre-exposure day, the animals in the pre-exposed
(PE) condition received either 50 or 100 exposures to the
to-be-conditioned white noise (experiments 3A and 3B,
respectively) presented at a variable inter-stimulus interval
of 40 s (ranging from 25 to 55 s), whilst the non-pre-
Fig. 1 Summary of the overall experimental design in the present study. PE pre-exposure condition, nPE non-pre-exposure condition, amph
amphetamine, PCP phencyclidine. Days of rest between experiments indicated just above or below the arrows
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exposed (nPE) subjects spent an equivalent amount of time
in the shuttle boxes without any programmed events except
for the house light.
On the next day, the animals were returned to the same
boxes and received 100 active avoidance trials presented
according to a random interval schedule (mean 40 s,
ranging from 25 to 55 s). A trial began with the onset of
the white noise CS. If the animal shuttled within 5 s of CS
onset, the CS was terminated and the animal did not receive
any foot shock: This was scored as an avoidance response.
Avoidance failure led to the immediate delivery of a foot
shock (presented in conjunction with the white noise CS)
that could last for a maximum of 2 s. A shuttle response
during this period would terminate both the CS and the foot
shock, and an escape response would be recorded.
Otherwise, when an animal failed to shuttle in the presence
of the shock, an escape failure was recorded. Shuttle
responses performed during the inter-trial intervals were
all without programmed consequence, but these were
recorded and analysed separately. Avoidance learning was
indexed by the number of successful avoidance responses
across successive blocks of ten trials. Retarded learning in
the PE subjects relative to the respective nPE controls
would constitute LI.
Locomotor response to psychostimulant drugs in the open
field
Apparatus The apparatus consisted of eight identical open
field arenas constructed from plastic laminated wood with a
waterproof white finish. Each arena measured 40×40 cm in
surface area and was surrounded on all sides by a 30-cm-
high wall. The experiment was conducted in two separate
testing rooms with diffused dim lighting (30 lx). Each room
housed four open field arenas positioned directly under a
digital camera that captured images from all four arenas at a
rate of 5 Hz. The images were transmitted to a personal
computer (PC) running the Ethovision (Noldus Technology,
The Netherlands) tracking system, and locomotor activity
was indexed by the cumulative displacement of the centre
of gravity of the subject's surface area over successive
frames, expressed in 10-min bins.
Procedures The allocation of animals between the two
testing rooms and amongst the eight arenas was counter-
balanced with respect to strains and drug conditions.
Immediately following the systemic injection (amphet-
amine, PCP or saline vehicle), each animal was gently
placed in the centre of the appropriate arena and allowed to
explore undisturbed for 2 h. They were not previously
habituated to the arena because we intended to capture the
unique profile of psychostimulant drug in association with
environmental novelty—an aspect that is critical to both
latent inhibition and prepulse inhibition on theoretical
grounds (e.g. Schmajuk and Larrauri 2005; Schmajuk et
al. 1996). Afterwards, they were returned to the home cage
and the arenas cleansed with water and dried prior to the
next squad. All solutions for injection were freshly prepared
on the day of testing and administered in a volume of
5 ml/kg body weight via the i.p. route. Amphetamine
(obtained from Sigma-Aldrich, Switzerland) and phencycli-
dine (PCP, donated by the National Institute for Drug
Addiction, USA) were dissolved in sterile physiological saline
to achieve the required doses of 2.5 and 5 mg/kg, respectively.
Statistical analysis
All data were analysed by parametric analysis of variance
(ANOVA) using the between-subject factors, strain, in
combination with drug and pre-exposures as appropriate.
Additional within-subject factors (e.g. 10-min bins, ten-trial
blocks) were also included according to the nature of the
considered dependent variables. To assist interpretation of
the statistical outcomes, significant effects were further
investigated by supplementary restricted analyses applied to
a subset of the data or by pairwise comparisons based on
the associated error terms taken from the overall ANOVA
whenever appropriate. To better conform to the normality
and variance homogeneity assumptions of parametric
ANOVA, logarithmic transformation (indicated as “ln-
transformed” in the text and figures) was applied to the
reactivity data in the prepulse inhibition experiment [ln
(reactivity score + e) − 1] (see Csomor et al. 2008). A
square-root transformation was likewise applied to the
number of inter-trial interval (ITI) crossings in the active
avoidance experiment as well as to the activity measure in
the open field experiment. All statistical analyses were
carried out using SPSS for Windows (release 13, SPSS,
Chicago IL, USA) implemented on a PC running the
Windows XP (SP3) operating system.
Results
Experiment 1: comparison of baseline PPI expression
in DBA/J2 and C57BL/6 mice
Here, both the expression of PPI and the acoustic startle
reflex were comprehensively evaluated using the parametric
design adopted from Yee et al. (2005) because of the
anticipated between-strain difference in startle reactivity.
Different data sets were derived from the test session and
subjected to separate analyses to address specific processes
as follows: (1) Startle reactions obtained in the first and last
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blocks of trials consisting only of pulse-alone trials were
used to assess startle habituation. (2) Evaluation of the
reaction to pulse-alone trials presented in the intermediate
block of trials, when they were intermixed with different
trial-types, allowed the assessment of startle reactivity that
would be expected to affect PPI assessment. (3) PPI
inhibition or reduction of startle reaction to the pulse
stimulus induced by a preceding prepulse stimulus was
assessed in an analysis of all pulse-alone and prepulse-plus-
pulse trials presented in the intermediate trial block. (4) PPI
expression as percent reduction of the startle response (%
PPI) was included here for the purpose of comparison with
previous studies that rely solely on this indexation of PPI,
although there are serious reservations for its application
when startle reactivity differed between treatment groups
(Csomor et al. 2008; Swerdlow et al. 2000; Yee et al. 2005).
(5) Whenever appropriate and feasible, additional compar-
isons of PPI between strains were conducted with an
attempt to balance the reactivity on pulse-alone trials by
contrasting the data derived from one pulse intensity in one
strain to the data obtained with another pulse intensity in
the other strain. This entire analytic approach was adopted
in experiments 1 and 2. All reactivity scores were subjected
to a logarithmic transformation (ln-transformed) prior to
statistical analysis as explained in “Materials and methods”
(also see Csomor et al. 2008; Yee et al. 2005).
Startle habituation
The first and the last six trials of the test session comprised
only pulse-alone trials (two trials per intensity: 100, 110 or
120 dBA). Comparison between these two blocks of six
trials allowed the assessment of long-term startle habitua-
tion. As illustrated in Fig. 2a, a marked decrease in the
startle reaction from the first to the last blocks was apparent
in the DBA/2 mice, but not in the C57BL/6 mice. Whereas
startle habituation was present in DBA/2 mice regardless of
pulse stimulus intensity, C57BL/6 mice displayed no
obvious tendency of habituation. If anything, C57BL/6
mice showed a tendency of sensitisation to the pulse
stimulus at the two lower intensities from the first to the
last blocks. These impressions were confirmed by a 2×2×3
(strain × blocks × pulse intensity) split-plot ANOVA, which
yielded a significant strain by blocks interaction [F(1,47)=
51.64, p<0.001], and the three-way interaction [F(2,148)=
9.44, p<0.001]. These were accompanied by a main effect
of blocks [F(1,74)=24.56, p<0.001], of pulse intensity
[F(1,74)=95.28, p<0.001] and of strain [F(1,74)=8.57, p=
0.005], indicating the overall presence of a habituation
effect and the monotonic dependency of startle reaction on
pulse intensity and that the two strains differed in startle
reactivity. Supplementary analyses restricted to each strain
confirmed the presence of a significant habituation effect in
the DBA/2 strain [blocks: F(1,39)=66.38, p<0.001], but
not in the C57BL/6 strain [F(1,35)=2.92, p=0.10].
Startle reaction in pulse-alone trials in the main block
The reaction obtained in pulse-alone trials in the main block
(i.e. as apart from the first and last blocks of pulse-alone
trials described above) was used in the assessment of PPI
and was therefore analysed separately. The results confirmed
the overall difference between the two mouse strains and that
this strain difference was proportional to the intensity of the
pulse stimulus (Fig. 2b, shaded region). These interpretations
were supported by a 2×3 (strain × pulse intensity) split-plot
ANOVA, which yielded a significant main effect of strain
[F(1,74)=19.72, p<0.001], pulse intensity [F(2,148)=
169.75, p<0.001] as well as their interaction [F(2,148)=
41.23, p<0.001]. Pairwise comparisons based on the error
variance associated with the significant interaction term
confirmed the presence of a significant strain difference
under the 110- and 120-dB conditions (p<0.0001), but not in
the lower intensity (100 dB) condition.
Prepulse inhibition: pulse-alone vs. prepulse-plus-pulse
trials
PPI is defined as the reduction of startle reaction to the
pulse stimulus when it is preceded by a prepulse stimulus,
relative to when it is not. Here, this was statistically
assessed using a within-subject factor that incorporated
both trial types as well as prepulse intensity, +0, +6, +12
and +18 dB, with +0 effectively referring to the pulse-alone
condition. This is the recommended method in analysing
treatment effects known to be confounded by a difference
in startle reactivity (Swerdlow et al. 2000).
As illustrated in Fig. 2b, the presence of PPI was evident
in both DBA/2 and C57BL/6 mice and across the three pulse
intensities. Increasing prepulse intensity (from “+0” repre-
senting pulse-alone condition) led to a monotonic reduction
in startle magnitude, and this reduction appeared more
pronounced in conditions with higher pulse intensity. The
steepness of the individual curves depicted may be inter-
preted as the efficacy of the increasingly intense prepulse
stimulus to inhibit more strongly the startle response elicited
by the pulse stimulus (see Yee et al. 2004b). Thus, the
depiction represented by Fig. 2b suggests that DBA/2 mice
were in general less responsive to the prepulse.
A 2×3×4 (strain × pulse intensity × prepulse intensity)
split-plot ANOVA revealed a significant main effect of
pulse intensity [F(2,148)=229.05, p<0.001], as expected.
The presence of a significant prepulse intensity effect
[F(3,222)=240.80, p<0.001] and its interaction with pulse
intensity [F(6,444)=10.26, p<0.001] confirmed the pres-
ence of PPI and its dependency on pulse intensity. The
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analysis also revealed significant differences between
mouse strains. The significant main effect of strain [F
(1,74)=11.65, p<0.05] and its interaction with pulse
intensity [F(2,148)=34.28, p<0.001] are in keeping with
the impressions obtained from the preceding analysis:
DBA/2 mice showed reduced overall startle reactivity,
and this strain difference was dependent on pulse
intensity. Concerning the comparison of PPI expression
between strains, the analysis also revealed a significant
strain by prepulse intensity interaction [F(3,222)=24.05,
p<0.001] and the three-way interaction [F(6,444)=10.26,
p=0.001]. These effects support the conclusion that in
DBA/2 mice, responsiveness to the prepulse was attenu-
ated, and this attenuation was dependent on pulse
intensity, apparently more pronounced at higher than
lower pulse intensities.
Startle-matched and cross-pulse intensity analysis of PPI:
pulse-alone vs. prepulse-plus-pulse trials
Because response in pulse-alone trials was highly compa-
rable between strains at the lowest pulse (100 dB), a
Fig. 2 Summary of the results in experiment 1. Based on the PPI test
session, the following data sets were derived and separately analysed.
a Comparison between the first and last blocks of the test session
comprising pulse-alone trials only with two trials of each pulse
intensity (100, 110 and 120 dBA, represented by increasing shades of
grey). Results of the two strains were plotted separately (left, DBA/2;
right, C57BL/6). b Average reactivity scores (following logarithmic
transformation) across 12 different types of trial definition obtained in
the intermediate block of the test session: pulse-alone trials (emphas-
ised by the shaded rectangular background) are denoted as “+0 dB”
in the abscissa. The intensity of the prepulse stimulus in prepulse-
plus-pulse trials was also denoted along the abscissa as +6, +12 and
+18 decibel units above the constant background noise level of
65 dBA. Three separate plots were illustrated corresponding to the three
pulse stimulus intensities: 100, 110 and 120 dBA, as indicated at the top.
c Response (again following a logarithmic transformation) obtained in
prepulse-alone trials (of three intensities) and in comparison to “no-
stimulus” trials. d Results in percent prepulse inhibition (%PPI) derived
from the same data set as illustrated in b. Circles, C57BL/6 strain;
squares, DBA/2 strain (regardless of fillings). All values are means with
associated standard errors (±SE) based on the respective ANOVA
conducted using SPSS for Windows (version 13)
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restricted ANOVAwas performed on data derived from this
particular test condition. As expected, the main effect of
strain was no longer significant (F < 1). The PPI effect was
confirmed by the presence of a significant main prepulse
effect [F(3,222)=45.11, p<0.001]. However, evidence of a
PPI deficit in the DBA/2 mice was weaker: The strain by
prepulse intensity interaction failed to achieve statistical
significance [F(3,222)=1.90, p=0.13]. Only the quadratic
trend of this interaction remained statistically significant
[F(1,74)=5.00, p<0.05]. Hence, there is tentative evidence
that DBA/2 mice exhibited a PPI deficiency relative to
C57BL/6 mice independent of the confounding reduction in
startle reactivity.
As a further and more stringent test of this assertion,
we next selected for comparison between the two strains
the highest pulse intensity (120 dB) data set from DBA/
2 mice and the lowest pulse intensity (100 dB) data set
from C57BL/6 mice. This effectively reversed the
difference in pulse-alone reaction between strains. A
2×4 (strain × pre-pulse intensity) split-plot ANOVA of
this data set revealed again a significant interaction
between strain and prepulse [F(3,222)=4.40, p<0.005],
which still supports the interpretation that the startle
response in DBA/2 mice was less sensitive to the
inhibition by the prepulse. The significant main effect of
strain [F(1,74)=38.06, p<0.001] in this analysis now
refers to overall startle response being higher in the DBA/
2 mice. The main effect of prepulse was also significant
[F(3,222)=42.64, p<0.001], indicating the overall pres-
ence of PPI.
Prepulse inhibition: percent startle inhibition
In conformity to the common method of PPI indexation
by percent startle reduction calculated with respect to the
corresponding pulse-alone condition, we also presented
our data using the expression %PPI = (pulse-alone −
prepulse-plus-pulse)/pulse-alone × 100%) using the un-
transformed reactivity scores for each of the nine (three
prepulse intensities × three pulse intensities) prepulse-
plus-pulse conditions (see Fig. 2d). A 2×3×3 (strain ×
pulse intensity × prepulse intensity) split-plot ANOVA
of %PPI revealed an overall strain effect [F(1,74)=38.40,
p<0.001], which is suggestive of a PPI deficit in the
DBA/2 mice. Dependency of this deficit on pulse
intensity was supported by the strain by pulse intensity
interaction [F(2,148)=5.79, p<0.005], which was accom-
panied by a significant main effect of pulse intensity
[F(2,148)=8.00, p<0.001]. The main effect of prepulse
intensity also achieved significance [F(2,148)=77.66, p<
0.001], confirming that increasing prepulse intensity led
systemically to stronger PPI. However, there was no
statistical evidence in this analysis that this effect of
prepulse intensity was modified by startle intensity (pulse
by prepulse interaction: F < 1).
Startle-matched and cross-pulse intensity analysis: percent
startle inhibition
In parallel with the preceding analysis, a supplementary
analysis on the %PPI measure restricted to the lowest pulse
(100 dB) condition when the pulse-alone reaction was
comparable between the two mouse strains was conducted.
This effectively circumvented the inappropriateness of
using %PPI measure under situations of pronounced startle
difference between groups. This 2×3 (strain × prepulse
intensity) split-plot ANOVA revealed a main effect of
prepulse intensity [F(2,148)=12.24, p<0.001] and its
interaction with strain [F(2,148)=3.26, p<0.05]. The latter
suggests that DBA/2 PPI deficiency is not dependent on the
confounding reduction in startle reactivity observed at the
higher pulse intensities (Fig. 2b, d).
Next, we conducted the cross-pulse intensity analysis
on the %PPI measure, as performed above on the
reactivity data. To this end, the %PPI data derived from
the highest pulse intensity (120 dB) data set of the DBA/2
mice were compared with that derived from the lowest
pulse intensity (100 dB) data set of the C57BL/6 mice. A
2×3 (strain × pulse intensity) split-plot ANOVA of this %
PPI data set also provided evidence for a relative PPI
deficiency in DBA/2 mice. This analysis yielded a
significant main effect of strain [F(1,74)=6.51, p<0.05],
prepulse [F(2,148)=6.51, p<0.001] as well as their
interaction [F(2,148)=3.43, p<0.05].
Reaction to prepulse-alone trials
Direct response to the prepulse stimulus can be of relevance
to the evaluation of changes in PPI expression (Csomor et
al. 2009; Yee and Feldon 2009; Yee et al. 2004a, b, 2005).
In comparison with the “no-stimulus” control condition, the
prepulse led to a monotonic increase in motor reaction
(Fig. 2c). This was largely comparable between the two
mouse strains. A 2×4 (strain × prepulse intensity) split-plot
ANOVA of the ln-transformed mean reactivity scores
yielded only a significant main effect of prepulse intensity
[F(3,222)=8.47, p<0.001].
Influence of body weight on startle reaction and PPI
expression
A difference in body weight represents a potential confound
in the measurement of startle response using piezoelectric
accelerometers to detect change in the animal's whole body
momentum. The body weight of all subjects was therefore
recorded prior to the PPI experiment and was highly
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comparable between strains. The mean (±SEM) body
weight was: C57BL/6=27.6±0.4 g, DBA/2=27.0±0.4 g.
A one-way ANOVA failed to reveal a significant strain
effect [F(1,74)=1.01, p=0.32]. It is therefore unlikely that
the divergence between the two strains in PPI expression
and startle reaction could be attributable solely to differ-
ences in body weight.
Experiment 2: effects of clozapine on PPI expression
in C57BL/6 and DBA/2 mice
Startle habituation
The finding of a strain-dependent habituation effect was
replicated, along with overall strain difference in startle
reactivity and the effect of pulse intensity. The results are
summarised in Table 1.
In keeping with the outcomes of experiment 1, a 2×2×
2×3 (strain × drug × blocks × pulse intensity) split-plot
ANOVA of the (ln-transformed) startle reactivity obtained
in the first and last blocks of the test session yielded a
main effect of blocks [F(1,34)=5.01, p<0.05], pulse
intensity [F(2,68)=67.44, p<0.001], strain [F(1,34)=
36.95, p<0.001] and the strain × blocks [F(1,34)=36.17,
p<0.001] as well as strain × pulse intensity interaction
[F(2,64)=28.24, p<0.001]. The directions of all these
effects were consistent with those observed in experiment
1. In addition, clozapine treatment did not affect startle
habituation (drug × block interaction: F < 1), nor did it affect
the overall levels of startle reactivity [drug: F(1,34)=2.07, p=
0.16]. However, there was a tendency that clozapine
pretreatment weakened reaction to the highest pulse
stimulus [drug × pulse intensity: F(2,68)=2.75, p=0.07].
This trend is worth noting in view of the following
analysis.
Startle reaction on pulse-alone trials in the main block
Again, the critical findings concerning strain differences
were in agreement with the outcomes of experiment 1.
Briefly, DBA/2 mice exhibited reduced startle reaction, and
this reduction was more pronounced at the higher pulse
intensities (see Fig. 3a, b). A 2×2×3 (strain × drug ×
pulse intensity) split-plot ANOVA of pulse-alone trials
derived from the middle block yielded a highly
significant main effect of strain [F(1,34)=65.71, p<
0.001] and its interaction with pulse intensity [F(2,68)=
23.55, p<0.001]. In addition, clozapine significantly
affected startle reactivity, and this drug effect also
depended on the intensity of the pulse stimulus. The
main effect of drug approached statistical significance
[F(1,34)=3.84, p=0.06], and the drug by pulse intensity
interaction was highly significant [F(2,68)=5.38, p<0.01]. Ta
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Similar to the effect of strain, the startle-attenuating effect
of clozapine was more notable at higher pulse stimulus
intensities, and this drug effect was apparent in both
mouse strains. Pairwise comparisons based on the error
variance associated with the significant drug by pulse
intensity interaction indicate that clozapine pretreatment
led only to a significant reduction in startle reactivity at
the pulse = 120-dB condition.
Prepulse inhibition
Confronted with a significant effect on startle reactivity of
clozapine treatment as well as between strains, analysis of
PPI expression by means of percent inhibition would be
highly problematic. Hence, we again adopted the analytical
approach in experiment 1 and conducted a 2×2×3×4
(strain × drug × pulse intensity × prepulse intensity)
ANOVA of the ln-transformed reactivity scores obtained
in both pulse-alone and prepulse-plus-pulse conditions (see
Fig. 3a, b).
The analysis yielded a main effect of pulse intensity
[F(2,68)=93.58, p<0.001], as expected. The overall pres-
ence of PPI and its dependence on pulse intensity were
evident from the significant effect of prepulse intensity
[F(3,102)=164.05, p<0.001] and its interaction with pulse
intensity [F(6,204)=8.37, p<0.001], respectively. A num-
ber of significant effects and interactions that emerged are
consistent with strain- and drug-induced differences in
startle reactivity as seen already in the previous two
analyses: strain [F(1,34)=27.97, p<0.001], strain × pulse
intensity [F(2,68)=20.46, p<0.001], strain × pulse intensity ×
prepulse intensity [F(6,204)=26.74, p<0.001], drug [F(1,34)=
6.99, p<0.05] and drug × pulse intensity [F(2,68)=4.82, p<
0.05]. As in experiment 1, the interaction between strain and
prepulse attained statistical significance [F(3,102)=45.27, p<
0.001], suggesting that the reactivity to the pulse stimulus was
Fig. 3 Summary of the results in experiment 2. The average reactivity
scores (following logarithmic transformation) across 12 different types
of trial definition obtained in the intermediate block of trials for
C57BL/6 mice and DBA/2 mice are depicted in a and b, respectively.
Pulse-alone trials are denoted as “+0 dB” in the abscissa. The intensity
of the prepulse stimulus in prepulse-plus-pulse trials was also denoted
along the abscissa as +6, +12 and +18 decibel units above the constant
background noise level of 65 dBA. Within a and b, three separate plots
are illustrated corresponding to the three pulse stimulus intensities:
100, 110 and 120 dBA, as indicated at the top. The shaded regions in a
and b highlight the respective pulse conditions between the two mouse
strains, which are explicitly compared in all subsequent figures (c–f). c
Cross-pulse intensity (startle-matched) comparison amongst the four
strain × drug conditions. d Drug effect derived from this startle-
matched comparison by contrasting the two drug conditions (cloza-
pine vs. saline) collapsed across strains. e Strain difference collapsed
across drug conditions. f Results expressed in percent inhibition (%
PPI) derived from this startle-matched comparison. All mean values
are illustrated with the associated standard errors (±SE) obtained from
the respective ANOVA conducted using SPSS for Windows (version
13). clz clozapine, sal saline, C57 C57BL/6 strain, DBA DBA/2 strain
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less modified by the prepulse stimulus in DBA/2 mice than in
C57BL/6 mice (see Fig. 3a, b).
However, the analysis yielded no suggestion that
clozapine treatment had modified the expression of PPI
in either strain. Neither the drug by prepulse intensity
interaction [F(3,102)=1.44, p=0.24] nor other higher
interaction terms consisting of these two factors achieved
statistical significance.
We next conducted an additional analysis in an attempt
to balance the startle reactivity across different between-
subjects conditions. To this end, the data (reactivity scores
obtained from pulse-alone and prepulse-plus-pulse trials)
derived from the pulse = 110-dB condition in DBA/2 mice
and the data derived from the pulse = 100-dB condition in
C57BL/6 mice were combined into a 2×2×4 (strain ×
drug × prepulse intensity) ANOVA (see Fig. 3c–e). As
expected, neither the main effects of strain nor drug were
significant, and the highly significant main effect of
prepulse intensity [F(3,102)=17.46, p<0.001] indicated
the presence of PPI. Most critically, this analysis yielded a
clear presence of a drug × prepulse intensity [F(3,102)=
3.62, p<0.05] and strain × prepulse intensity interaction
[F(3,102)=3.07, p<0.05]. These two interaction effects
are depicted separately in Fig. 3d and e, respectively,
showing that clozapine exerted an overall PPI-enhancing
effect, whereas DBA/2 mice showed a reduction in PPI
expression relative to C57BL/6 mice. Figure 3c shows that
the clozapine treatment effect was present in both mouse
strains.
Next, this specific startle-matched data set (comprising
data derived from the lowest pulse condition from C57BL/6
mice and the middle pulse condition from DBA/2 mice)
was expressed as percent inhibition (%PPI) since the startle
reactivity on pulse-alone trials was now largely balanced
(see Fig. 3f). The statistical outcomes complemented
perfectly the impressions described above, yielding a
significant effect of drug [F(1,34)=9.14, p<0.005] and of
strain [F(1,34)=11.23, p<0.005]. There was again no
indication of any interaction between these two between-
subjects factors (F < 1).
Reaction to prepulse-alone trials
Separate analysis of the reaction to the prepulse-alone
trials by a 2×2×4 (strain × drug × prepulse intensity)
ANOVA only yielded a significant main effect of prepulse
intensity [F(3,102)=3.60, p<0.05]. Neither mouse strain
nor clozapine pretreatment was associated with any
significant change in prepulse-elicited reaction. The
results are summarised in Table 1, instead of graphically
because of the considerable overlap between conditions.
The lack of a strain difference in this measure was
consistent with the outcome from experiment 1. The
absence of a drug effect was instrumental in showing that
it had not altered the direct perception or reaction to the
prepulse stimuli.
Experiment 3A: strong latent inhibition of active avoidance
learning (100 pre-exposures of the CS)
Pre-exposure day
The total number of shuttle responses recorded in the pre-
exposure phase was subjected to a two-way (strain ×
stimulus pre-exposure) ANOVA following a square-root
transformation. As a measure of activity, this yielded a
significant effect of strain [F(1,12)=10.69, p<0.01], with
DBA/2 mice performing significantly more spontaneous
shuttles than C57BL/6 mice. On the other hand, this
measure was not affected (F < 1) by whether the animals
were in the PE or nPE condition. The mean (square-root-
transformed) total numbers of shuttles recorded in each of
the four groups were: DBA/2-nPE=15.77, DBA/2-PE=
15.18, C57BL/6-nPE=11.26, C57BL/6-PE=12.01 (stan-
dard error of differences, SED=1.18).
Conditioning day
Stimulus pre-exposure resulted in an attenuation of avoid-
ance learning on the conditioning day, constituting the LI
effect. LI was readily detected in the C57BL/6 mice, but
was distinctly absent in the DBA/2 mice (see Fig. 4a). A
2×2×10 (strain × stimulus pre-exposure × 10-trial blocks)
split-plot ANOVA of avoidance successes yielded a
significant effect of blocks [F(9,108)=21.01, p<0.001]
indicative of a general improvement of avoidance perfor-
mance over successive blocks of training. The main effect
of pre-exposure approached statistical significance [F
(1,12)=4.34, p=0.06], which could be considered as
significant, however, if a one-tailed criterion is adopted,
given that expectation of an LI effect has specified the
direction of the pre-exposure effect. Finally, the interaction
between strain and pre-exposure just reached the margin of
statistical significance [F(1,12)=4.58, p<0.05]. Pairwise
comparisons confirmed the presence of a significant LI
effect in the C57BL/6 mice (p<0.05), but not in the DBA/2
mice. Comparison between strains restricted to either pre-
exposure condition did not yield any significant differences,
suggesting that the loss of LI in the DBA/2 mice was
attributable to the combined strain differences in both PE
and nPE conditions.
The number of spontaneous shuttle responses recorded
during the ITIs on the conditioning day was subjected to a
2×2×10 (strain × stimulus pre-exposure × 10-trial blocks)
split-plot ANOVA following a square-root transformation.
The results indicated that DBA/2 mice were more active
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and did not show any sign of reduction over the course of
the test session as did the C57BL/6 mice (see Fig. 4b).
Stimulus pre-exposure did not lead to any change in this
spontaneous activity index. These impressions were con-
firmed by the significant effect of strain [F(1,12)=61.07,
p<0.001], blocks [F(9,108)=13.25, p<0.001] and their
interaction [F(9,108)=8.37, p<0.001].
Experiment 3B: weak latent inhibition of active avoidance
learning (50 pre-exposures of the CS)
Pre-exposure day
DBA/2 mice again performed more spontaneous shuttles
than C57BL/6 mice on the pre-exposure day regardless of
pre-exposure condition. However, in this experiment, this
effect just failed to achieve statistical significance. A two-
way (strain × stimulus pre-exposure) ANOVA yielded a
marginal effect of strain [F(1,12)=4.14, p=0.06]. No other
effects including the interaction term were either close to or
achieved statistical significance. The mean (square-root-
transformed) numbers of total shuttles recorded in each of
the four groups were: DBA/nPE=7.97, DBA/PE=9.53,
C57/nPE=7.70, C57/PE=7.20 (standard error of differ-
ences, SED=0.64).
Conditioning day
As expected, 50 stimulus pre-exposures did not lead to a
significant LI effect in the C57BL/6 mice. Against this
background, DBA/2 mice did not show any tendency to
exhibit LI. If anything, the direction of the pre-exposure
effect was opposite to that of the LI effect. Overall, DBA/2
mice now appeared to show a general impairment in
Fig. 4 Summary of the results in experiments 3A and 3B. Two
variables were obtained on the conditioning day. (1) The number of
avoidance successes expressed as a function of successive ten-trial
blocks (on the left) or collapsed across blocks (on the right) for
experiment 3A (a) and Experiment 3B (c), respectively. (2) The
number of spontaneous shuttle responses recorded in the inter-trial
intervals (square-root-transformed) across successive ten-trial blocks
or collapsed across blocks were likewise illustrated in b and d for
experiments 3A and 3B, respectively. Asterisk refers to a significant
(p<0.05) main effect of strain (in b–d) and, in addition, the selective
presence of a significant pre-exposure effect in the avoidance learning
in C57BL/6 mice in experiment 3A (shown in a) and a significant pre-
exposure effect in the measure of inter-trial intervals spontaneous
shuttles in DBA/2 mice (shown in d). All mean values are illustrated
with the associated standard errors (±SE) obtained from the respective
ANOVA conducted using SPSS for Windows (version 13), which are
appropriate for comparison between the illustrated mean values
688 Psychopharmacology (2009) 206:677–698
avoidance learning in comparison to C57BL/6 mice, which
is consistent with the impression obtained in the nPE
condition of experiment 3A. A 2×2×10 (strain × stimulus
pre-exposure × 10-trial blocks) split-plot ANOVA of
avoidance successes revealed only a significant main
effect of strain [F(1,12)=12.53, p<0.005], of blocks [F
(9,108)=26.76, p<0.001] and their interaction with blocks
[F(9,108)=10.78, p<0.001].
Analysis of spontaneous shuttles during ITIs again
revealed a strain difference similar to that seen in
experiment 3A: DBA/2 mice were hyperactive and their
spontaneous shuttle activity failed to show any habituation.
The main effect of strain [F(1,12)=41.13, p<0.001], of
blocks [F(9,108)=2.55, p<0.05] and their interaction [F
(9,108)=5.82, p<0.001] again emerged as being highly
significant. In addition, the levels of spontaneous activity
exhibited by DBA/2 mice in this experiment appeared also
to be dependent on the pre-exposure condition—a tendency
that was not present in experiment 3A, when twice as many
CS-pre-exposures had been experienced by the PE animals
on the previous day (i.e. in the pre-exposure phase). This
resulted in a near-significant interaction between strain and
pre-exposure [F(1,12)=4.48, p=0.056], and pairwise com-
parisons revealed that DBA/PE subjects performed signif-
icantly more spontaneous shuttles than subjects in all other
conditions (minimal p<0.02).
Experiment 4: Motor stimulating effects of acute
amphetamine or phencyclidine treatment
Activity in the open field under vehicle treatment condition
confirmed the impression obtained in experiments 3A and
3B that DBA/2 mice were spontaneously more active than
C57BL/6 mice (Fig. 5a). Indeed, the same animals in
experiment 4 had participated in experiments 3A and 3B.
Both mouse strains responded to the psychostimulant drugs
with an elevation of motor activity. Examination of the
temporal expression of the drug effect suggest that DBA/2
mice responded more quickly to amphetamine, achieving
peak response almost within the first 10 min, whilst it took
C57BL/6 mice nearly 30 min to reach peak response
(Fig. 5b). The peak response magnitude appeared compa-
rable between strains, and by the end of the 2-h observation
period, activity between the two strains was comparable,
but was still higher than their respective vehicle-treated
controls. In contrast, the immediate response to acute PCP
injection was highly comparable between DBA/2 and
C57BL/6 mice. However, DBA/2 mice showed a sustained
and elevated (relative to DBA/saline subjects) response
throughout the 2-h period, whereas activity levels in
C57BL/6 mice showed a consistent (except from bins 8 to
9) monotonic reduction following the immediate peak
(Fig. 5c). Hence, although DBA/2 mice showed some form
of hyperresponsiveness to amphetamine and PCP in
comparison to C57BL/6 mice, the precise temporal dynam-
ic of this strain difference differed substantially between the
two pharmacologically distinct drugs.
The interpretations above were substantiated by the
results of a 2×3×12 (strain × drug × 10-min bins) split-
plot ANOVA of distance travelled (square-root-trans-
formed) per bin. All main effects attained statistical
significance: strain [F(1,26)=34.73, p<0.001], drug [F
(2,26)=74.64, p<0.001] and bins [F(11,286)=15.00, p=
0.001]. The presence of a strain by drug interaction [F
(2,26)=6.85, p<0.005] and the three-way interaction [F
(22,286)=3.90, p=0.001] confirmed the differences be-
tween strains in terms of their overall activity levels, and
that the temporal profiles differed between the three drug
conditions. Because the drug-induced activity profile
differed between the two drugs (and in comparison to
saline vehicle), the interaction between drug and bins was
also highly significant [F(22,286)=7.87, p<0.001].
Pairwise comparisons between strains under each treat-
ment condition confirmed the impression that the two
strains differed under vehicle condition (p<0.001) and
following PCP treatment (p<0.001), but not when they
were both under the influence of amphetamine (p=0.60).
The latter supported the interpretation that the two strains
differed primarily in their temporal response to amphet-
amine. This emphasis was also confirmed by supplemen-
tary restricted analyses: A significant strain by bins
interaction was only evident in the analyses restricted either
to the amphetamine [F(11,110)=2.29, p<0.05] or PCP [F
(11,110)=8.03, p<0.001] conditions, whereas the strain
difference was stable over time in the absence of a drug
challenge (vehicle condition).
Discussion
The present study represents a comprehensive evaluation of
the DBA/2 mouse strain in schizophrenia-related endophe-
notypes and its reaction to acute psychostimulant drug
challenge in comparison to the C57BL/6 strain. This strain
comparison has revealed a number of behavioural diver-
gences that may be interpreted as the presence of multiple
schizophrenia-related traits in DBA/2 mice (or, alternative-
ly, of an antipsychotic profile in C57BL/6 mice). This
includes, first of all, the relative deficiency in prepulse
inhibition and latent inhibition, which parallel that reported
in schizophrenia patients (e.g. Baruch et al. 1988; Braff et
al. 2001, 1992; Gray et al. 1992). The difference in motor
response to acute psychostimulant drug challenge further
indicates that dopaminergic as well as glutamatergic/
NMDA receptor functions also diverge between these two
mouse strains. It is, however, premature to conclude that
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these presumed differences in neurotransmission function
are causally related to the behavioural divergence observed.
In addition to confirming earlier speculations on the
behavioural and cognitive characteristics of DBA mice
(e.g. Baarendse et al. 2008; Olivier et al. 2001), the present
study also provides fresh insights that are highly relevant to
the purported use of this strain comparison as a means to
model selected schizophrenia traits in animals in terms of
face, predictive (of drugs with antipsychotic potential) and
construct (e.g. genetic, developmental and physiological
differences) validity.
Deficient prepulse inhibition against a background
of reduced startle reactivity in DBA/2 mice
We have first addressed the reliability of the reported
relative PPI deficiency in DBA/2 mice because it is known
that confounding change in startle reaction has been
repeatedly noted in previous reports (e.g. Bortolato et al.
2007; Crawley et al. 1997; McCaughran et al. 1997; Paylor
and Crawley 1997). Ignoring such confounding differences
in startle reactivity can seriously undermine the validity of
any claim as to whether PPI expression differs between
groups (see Swerdlow et al. 2000). As can be readily seen
in Figs. 2a and 3b, the absolute reduction in startle
reactivity was heavily influenced by the corresponding
baseline reactivity to the startle-eliciting pulse stimulus in
C57BL/6 mice: This sensitivity to the prepulse stimulus
was less pronounced when the startle reaction to the pulse
stimulus was weaker. Hence, it is not inconceivable that the
apparent deficiency in PPI observed in DBA/2 mice was
related to their generally weaker startle reactivity. It
therefore poses an important interpretative problem because
this confound might lead to the identification of startle-
corrective therapy rather than PPI-corrective treatment. To
overcome this confounding effect, we adopted a recently
developed PPI test paradigm incorporating multiple pulse
stimulus intensities (Yee et al. 2005), which allowed the
startle reaction between the two strains to be balanced or
even reversed, thus providing an insight into a possible
dependency on the existing strain difference in startle
reactivity. The principle of its application is similar for
both experiments 1 and 2, although the critical (crossed
pulse intensity) comparisons being emphasised differed
somewhat. The conclusions were identical: The relative PPI
deficiency in DBA/2 mice cannot be solely attributed to
their weaker startle response. The robustness and flexibility
of this analytical approach in overcoming baseline startle
reactivity difference in general was thus also demonstrated
(Csomor et al. 2008; Yee et al. 2005). Based on this
approach, we can also conclude that DBA/2 mice cannot be
characterised as “low-startling” C57BL/6 mice in terms of
the PPI expression. We have previously shown that when a
random sample of C57BL/6 mice were segregated into
subgroups differing in startle reactivity, and the subgroups
then compared, the apparent differences in PPI indexes
Fig. 5 Summary of the results of experiment 4. Distance travelled per
10-min bins following vehicle saline (a), amphetamine (b) and
phencyclidine (PCP) (c) is separately plotted to contrast the two
mouse strains (C57 C57BL/6, DBA DBA/2). Insets in each graph
represent the mean distance travelled per bin collapsed across bins to
illustrate the relative augmentation of locomotor response in DBA/2
mice (in a and c, as indicated by asterisk). All mean values are
illustrated with the associated standard errors (±SE) obtained from the
overall three-way ANOVA conducted using SPSS for Windows
(version 13), which are appropriate for comparisons between the
illustrated mean values
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calculated according to convention (%PPI) would be
eliminated when a crossed pulse intensity comparison was
conducted to balance the reaction on pulse-alone conditions
(Yee et al. 2005). This method of analysis thus showed that
PPI expression was essentially comparable between
C57BL/6 mice differing in startle magnitude. There is no
reason to suspect that the same situation would not hold for
other inbred mouse strains. Hence, the confirmation of the
strain difference in PPI expression in the present study has
clarified considerably the concern over the confounding
difference in startle reactivity. We conclude that the
regulation of PPI expression was different between these
two mouse strains.
A schizophrenia-related trait in C57BL/6 in comparison
to DBA/2 mice?
Experiment 1 showed clearly the absence of startle
habituation in C57BL/6 mice against the clear presence of
startle habituation in the DBA/2 mice (Fig. 2a). A
consistent pattern of results was replicated in experiment
2 (Table 1). Indeed, the lack of startle habituation in
C57BL/6 mice is a robust result in agreement with earlier
reports (Pietropaolo et al. 2008; Yee et al. 2004a, 2005).
Given that impairment in startle reflex habituation is also
present in schizophrenia patients and may be related to
impaired selective attention (Geyer and Braff 1987; Geyer
et al. 1990), should one also consider this strain-specific
trait as a potential schizophrenia-related endophenotype?
This certainly warrants further assessment, including the
psychological nature of this phenotype as well as its
relationship to PPI disruption in patients. Our data provide
three relevant perspectives in this regard: (1) Clozapine was
ineffective in promoting startle habituation in C57BL/6
mice (see Table 1), although the mice were responsive to
the drug in terms of PPI expression (experiment 2). (2) The
PPI deficiency demonstrated in DBA/2 mice relative to
C57BL/6 mice was obviously not associated with an
impairment in startle habituation (experiments 1 and 2).
(3) The startle habituation deficit seen in C57BL/6 mice
cannot be generalised to other responses because habitua-
tion of locomotor activity in the open field was equally
observed in C57BL/6 and DBA/2 mice (Fig. 4a). Hence, it
is unlikely that C57BL/6 mice suffer from a generalised
weakening of habituation and/or strengthening of sensitisa-
tion processes.
It has not escaped our notice that the presence of startle
habituation in DBA/2 but not C57BL/6 mice might have
contributed to the overall strain difference in startle
reactivity seen across the test session (as recorded in the
middle block of the test session used to assess PPI). We
therefore explicitly compared all PPI-related measures by
splitting the session into two halves and repeated all
relevant analyses. This did not yield any deviation from
our overall conclusion described above. Therefore, the
difference in startle habituation does not undermine the
confidence in our interpretations of the PPI data. Our results
point to an intriguing double dissociation1 in this strain
comparison, with deficiency in one form of startle plasticity
found only in one mouse strain (PPI deficiency in DBA/2)
and another form of anomaly only in the other strain (startle
habituation deficit in C57BL/6). Interestingly, both pheno-
types are of relevance to schizophrenia. This double
dissociation in itself calls for caution in the use, or
interpretation, of a given pairwise strain comparison as a
general model of schizophrenia because either strain may
be considered as more or less schizophrenia-like. The
comparison should be made in a trait-by-trait, or
endophenotype-by-endophenotype, manner (Arguello and
Gogos 2006).
Responsiveness to systemic clozapine in PPI expression
Experiment 2 examined whether the baseline difference in
PPI expression which emerged between DBA/2 and
C57BL/6 mice would suggest that the former strain might
therefore be more powerful in detecting the effect of
atypical antipsychotic drugs, as exemplified by clozapine.
If so, then one may conclude that the DBA/2 strain may
represent a disease model such that its sensitivity to
antipsychotic drugs signifies a correction or normalisation
of PPI function, at least within the restrictive comparison to
C57BL/6 mice. Thus, the answer to this question would
bear significance for the increasingly widespread use of
DBA/2 mice (often exclusively, without a comparison
strain) as a model to detect the PPI-corrective property of
novel antipsychotic drugs (e.g. Boulay et al. 2008;
Depoortère et al. 2005; Fox et al. 2005; Kinney et al.
2003), as if another strain would yield a false negative
outcome. The results of experiment 2 are clear: Against a
demonstrated baseline (vehicle treatment) strain difference
in PPI expression (Fig. 3e), clozapine was efficacious in
significantly enhancing PPI in both mouse strains (Fig. 3d).
These findings therefore do not support the suggestion that
DBA/2 mice are superior (at least to C57BL/6 mice) in
detecting the effect of atypical antipsychotic drugs (cloza-
pine here) on PPI. This conclusion is consistent with an
earlier study by McCaughran et al. (1997) who showed that
the C57BL/6 and DBA/2 were similarly effective in
detecting the PPI-enhancing effect of clozapine as well as
1 Strictly speaking, this is not a classical double dissociation due to a
lack of a common control comparison group against which the DBA/2
and C57BL/6 strains can be compared. Here, DBA/2 mice showed a
relative impairment in PPI, whilst C57BL/6 mice exhibited a lack of
startle habituation when they were compared with each other.
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other atypical and typical antipsychotic drugs. However, a
dose–response analysis would be necessary to consolidate
such a claim by showing that when startle reactivity is
balanced between strains, the dose–response curves of the
two strains would overlap each other. Our present experi-
ment had investigated a single dose of clozapine only, and
the conclusion therefore needs to be restricted to that
particular dose. Nonetheless, the responsiveness of C57BL/
6 mice to this dose was clear and comparable to that seen in
DBA/2 mice.
Again, the crossed pulse intensity analysis has been
highly instrumental in allowing us to arrive at this critical
conclusion amidst the confounding effects on startle
reactivity (pulse-alone trials) of clozapine treatment as well
as between mouse strains. It also suggests that at the highest
pulse intensity of 120 dB, clozapine merely produced an
overall downward shift of startle reactivity in both mouse
strains (Fig. 3a, b). In such case, expression of PPI as
percent startle inhibition relative to pulse-alone reactivity
would give an erroneous impression of PPI enhancement.
This is most obviously seen in the report by Ouagazzal et
al. (2001) who claimed that clozapine was effective in
enhancing PPI, based on %PPI analysis alone, at a dose of
30 mg/kg when startle response was massively reduced to
less than one fifth of the control group level (i.e. a 82%
reduction in startle reactivity) due presumably to the
sedative effect of clozapine at such high doses. Our analysis
overcame this problem and further indicated that the PPI-
enhancing effect of clozapine was more readily shown in
both strains at lower pulse intensities (100–110 dB). This
may suggest that if DBA/2 mice are more sensitive to this
effect of clozapine (and by extension other atypical
antipsychotic drugs), it is because they inherently exhibit
lower startle reactivity. This, however, can be readily
mimicked by the use of lower pulse intensity in C57BL/6
mice, and under such conditions, the PPI-enhancing effect
of clozapine can also be readily detected. Hence, whilst we
showed that the PPI deficiency of DBA/2 relative to
C57BL/6 mice cannot be explained solely due to the
confounding change in startle response (experiment 1), the
reported impression that DBA/2 mice seem to be more
suitable for the detection of atypical antipsychotic property
in PPI may indeed stem from the reduced startle reaction
native to this mouse strain. This highlights another
important potential benefit of PPI tests that include multiple
pulse stimulus intensities.
Another possibility is that DBA/2 mice were more
responsive than C57BL/6 to disruption by NMDA receptor
antagonists and thereby more suitable or sensitive in
detecting atypical antipsychotic drugs (Geyer 2006a, b).
First of all, PPI expression in C57BL/6 is indeed sensitive
to NMDA receptor antagonism (Yee et al. 2004a), so the
comparison must be based on relative rather than absolute
sensitivity. Using a dose–response analysis (0, 10, 15 or
20 mg/kg), Spielewoy and Markou (2004) compared the
sensitivity to PCP in four mouse strains (C57BL/6, DBA2,
C3H/He and 129T2/SvEms) and concluded that C57BL/6
was the least sensitive, or even statistically insensitive.
However, it seems that these authors have overinterpreted
their own data since the conclusion was inconsistent across
experiments (see their Figs. 1 and 3). Closer examination of
their data also suggests that the dose–response relationship
in C57BL/6 mice was somewhat shifted to the left of that of
DBA/2 mice (see their Fig. 1a, b). Finally, their PPI
evaluation failed to take into account the demonstrated
strain-dependent effects of PCP treatment on startle
reactivity that would certainly confound the interpretation
of the data (see their Fig. 2). We therefore conclude that
there is no convincing evidence to date to suggest that
DBA/2 and C57BL/6 mice differ substantially in their
responsiveness to NMDA antagonists-induced PPI disrup-
tion. This issue should be addressed directly, but caution
over confounding changes in startle reactivity must be
exercised.
Beyond PPI deficiency
DBA/2 mice exhibited a parallel deficiency in the expres-
sion of LI under conditions in which C57BL/6 mice
showed robust LI (Experiment 3a, Fig. 4a), thereby
extending the recent finding by Baarendse et al. (2008)
who compared LI expression between DBA/2 and C57BL/
mice in a passive avoidance paradigm. Similar to PPI, LI is
also impaired in at least a subset of schizophrenia patients
(e.g. Baruch et al. 1988; Gray et al. 1992). Whilst PPI is
suggested to measure the pre-attentive filtering or gating
process (e.g. Ellenbroek 2004; Geyer 2006a), LI is more
closely related to learned inattention, i.e. learning to ignore
irrelevant stimuli in one’s environment (e.g. Gray et al.
1991, 1995; Lubow 1989; Mackintosh 1973; Wagner
1978). The concomitant presence of PPI and LI deficiency
(in DBA/2 mice relative to C57BL/6 mice) demonstrated
here in a within-subject manner lends further evidence that
this strain comparison may capture more than one endo-
phenotype related to schizophrenia.
The particular form of LI disruption in DBA/2 mice
came about through a loss of the stimulus pre-exposure
effect, i.e. CS pre-exposure failed to slow down subsequent
learning about the predictive value of that stimulus, as well
as through an impairing effect on learning in the non-
pre-exposed condition—a novel finding that was most
clearly shown in experiment 3B (Fig. 4c). It has been
suggested that the latter effect might be interpreted as: (1) a
general learning deficit—the DBA/2 mice learned less
about the CS–US association, just as the DBA/2 PE mice
had learned less about the CS–nothing association or the
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irrelevance of the CS during pre-exposure (see Yee et al.
1995), or (2) a failure to benefit from the context pre-
exposure effect (i.e. latent inhibition to the context (e.g.
Killcross et al. 1998), which should reduce the salience of
the context and enhance attention to the CS (and thereby
learning of its predictive significance) during subsequent
conditioning for the NPE animals (see Pouzet et al. 2004).
It should also be emphasised that the relative deficit in
avoidance learning in DBA/2 mice was expressed against
the background of enhanced spontaneous shuttle responses
recorded in the ITIs, with C57BL/6 mice exhibiting very
low levels of spontaneous shuttles from the second block
onwards. Hence, the poorer performance in DBA/2 mice
cannot be explained by the relative difference in spontane-
ous shuttles. The higher spontaneous shuttle rate in DBA/2
mice would, if anything, allow some successful avoidance
responses to be made by chance alone. The conclusion that
DBA/2 mice are impaired in at least this form of associative
learning is a novel observation that certainly warrants
further evaluation. This is in direct conflict with two
previous studies showing an opposite strain difference in a
similar two-way active avoidance task (Bovet et al. 1969;
Vetulani et al. 1989) when training was extended beyond
the first hundred trials. Although we had only performed
100 trials here, it is unlikely that our observed pattern of
results would reverse if additional training was conducted.
A survey on the existing literature, however, does not seem
to yield a clear consensus on this particular strain difference
in avoidance learning, with some reports also failing to
identify any clear performance difference (see Bovet et al.
1969; Iso and Shimai 1991; Sprott and Stavnes 1975;
Stavnes and Sprott 1975b; Vetulani et al. 1989; Wahlsten
1972; Weinberger et al. 1992). A number of factors have
been proposed to account for such apparent inconsistency,
including shock intensity (Carran et al. 1964; Wahlsten
1972), the modality of the conditioned stimulus (Oliverio
1967), the training protocol (Wimer et al. 1968) and the age
of the animals (Stavnes and Sprott 1975a). Another
possibility is the precise source or stock of the mice
obtained. Genetic drift away from the original Jackson
stocks may occur to varying degrees depending on the
breeding system maintained by the supplying laboratory.
Unfortunately, no single factor can yet fully account for
all reported results.
With respect to the precise pattern of LI abolition shown
in experiment 3A, it closely resembles that seen following
cell lesion of the entorhinal cortex (Yee et al. 1995, 1997),
which abolishes LI via a disruption of the entorhinal–
striatal projection, thereby disturbing the balance between
glutamatergic and dopaminergic activities in the nucleus
accumbens (Gray et al. 1995). On the other hand, it is
distinctly different from the effect of cell lesions of the
hippocampus, which lead to abnormally persistent LI
(Honey and Good 1993). It therefore contradicts the
description of the DBA/2 strain (in comparison of the
C57BL/6 strain) as a model or manifestation of a loss of
hippocampal function, with relatively poor performance
(compared with C57BL/6 mice) in tasks requiring the
formation of complex contextual representations including
spatial learning as well as contextual fear conditioning (e.g.
Ammassari-Teule et al. 2000a, 2000b, 1995; Barber et al.
1974; Gerlai 1998; Paylor et al. 1993, 1994; Wehner et al.
1990; Wimer et al. 1976).
The aberrant persistence of LI expression has been
emphasised by Weiner (2003) as a model of negative and
cognitive symptoms of schizophrenia. It can be induced in
animals by NMDA receptor blockade or selective brain
lesions to the nucleus accumbens core, basolateral amyg-
dala or orbitofrontal cortex, and its normalisation has been
specifically linked to atypical (but not typical) antipsy-
chotic drugs (Gaisler-Salomon and Weiner 2003; Gaisler-
Salomon et al. 2008; Lipina et al. 2005; Schiller et al.
2006). Experiment 3B examined this possibility by using a
smaller number of stimulus pre-exposures, which was
insufficient to generate LI in C57BL/6 mice (and the
sensitivity of this procedure to the induction of abnormal-
ly persistent LI by NMDA receptor blockade has been
confirmed in our laboratory; W-N. Zhang, P. Singer, J.
Feldon, and B.K. Yee, unpublished data). Against this
background, LI was similarly absent in the DBA/2 mice,
which also exhibited again an overall deficit in avoidance
learning. Extension of this null finding to other procedural
manipulations designed to minimise LI expression in the
reference control group (e.g. increased number of CS–US
pairings or contextual change between pre-exposure and
conditioning) would be highly relevant. One previous
study has reported that 16 CS pre-exposures (distributed
across 4 days) followed by two CS–US pairings in a
conditioned freezing paradigm led to LI in DBA/2 but not
C57BL/6 mice (Restivo et al. 2002), but the statistical
evidence provided was weak, and careful examination
revealed that their test condition was far from ideal—with
a trend of LI effect obtained in C57BL/6 mice, reportedly at
p=0.06.
According to the “two-headed” latent inhibition model
of schizophrenia formulated by Weiner (2003), our LI
experiments with DBA/2 mice would suggest an interpre-
tation of this mouse strain in terms of positive symptoms
rather than negative/cognitive symptoms of schizophrenia.
The latter in particular would disagree with the suggestion
that the PPI relative deficiency demonstrated in experi-
ments 1 and 2 would be predictive of cognitive symptoms
in schizophrenia (Geyer 2006a). As discussed below, the
outcomes of the psychostimulant drugs experiment have
yielded some support to both perspectives in terms of
neuropharmacology.
Psychopharmacology (2009) 206:677–698 693
Altered locomotor response to dopamine receptor agonism
and NMDA receptor antagonism in DBA/2 mice
One physiological perspective on the distinction between
positive and negative/cognitive symptoms of schizophrenia
emphasises the respective contributions of dopaminergic
hyperfunction and glutamatergic/NMDA receptor hypo-
function. As mentioned above, these two hypothesised
pathophysiological mechanisms are both highly relevant to
the interpretation and application of the PPI and LI models
of the relevant psychopathology. The LI phenotypes of
DBA/2 mice here are suggestive of dopaminergic dysfunc-
tion (Weiner 2003), whereas the PPI deficiency and its
responsiveness to clozapine may be indicative of glutama-
tergic/NMDA receptor hypofunction (Geyer 2006a, b).
These suggestions were therefore examined by acute
systemic challenge of a dopamine-releasing drug (amphet-
amine) or an NMDA receptor blocker (PCP) in these
animals (experiment 4).
First of all, a clear baseline difference was observed with
DBA/2 mice showing a higher level of activity (Fig. 5a),
which was also seen on the pre-exposure day of the LI
experiments with a different activity measure, namely total
number of spontaneous shuttles (experiments 3A and 3B).
We have since also replicated this finding in a separate
cohort of naïve DBA/2 and C57BL/6 mice, and thus, prior
test experience here does not seem to account for the
present outcome (P. Singer, J. Feldon and B.K. Yee,
unpublished observation). This impression is in keeping
with some (Morse et al. 1993; Tohmi et al. 2005) but not
other reports that have either shown an opposite pattern of
results (e.g. Cabib et al. 2000, 2002; McNamara et al. 2006)
or failed to reveal any difference between these two mouse
strains (Cabib et al. 2000; Ventura et al. 2004). Such
inconsistency may stem from the critical importance of
environmental factors including housing conditions (Morse
et al. 1993), feeding regime (Cabib and Bonaventura 1997)
and light/dark phase of the diurnal cycle (P. Singer, J.
Feldon and B.K. Yee, unpublished observation). Such
environmental factors in conjunction with the reported
enhanced sensitivity to stress in DBA/2 mice in comparison
to C57BL/6 mice (see e.g. Badiani et al. 1992; Cabib et al.
2000) may also contribute to the observed results in the
drug phase of the experiment here.
Although the baseline (vehicle treatment) difference
between strains renders interpretation of the overall
magnitude of drug-induced locomotor response somewhat
difficult, the temporal profile of the response clearly
differed between the two mouse strains. The onset and
offset of the peak response to amphetamine were acceler-
ated in DBA/2 mice by 10–20 min relative to C56BL/6
mice (Fig. 5b), with little change in the overall absolute
activity levels. This outcome is in conflict with previous
studies reporting a relative reduction of motor response
in DBA/2 mice that has been linked to an increase in
amphetamine-induced dopamine release in the prefrontal
cortex, which in turn suppresses dopamine release in
the nucleus accumbens that mediates the hyperactivity
effect (Ventura et al. 2004; Zocchi et al. 1998). However,
when the baseline difference in activity level observed
here is taken into account, the motor stimulant effect
of amphetamine might, on the contrary, be considered
weaker in the DBA/2 mice relative to the C57BL/6 mice
and would not be in direct disagreement with the reports
by Ventura et al. (2004) and Zocchi et al. (1998).
Nonetheless, the more rapid onset of hyperlocomotor
response to amphetamine in the DBA/2 mice here might
be expected on the basis of known dopaminergic differ-
ences between DBA/2 and C57BL/6 mice. Firstly, a
relative reduction in D2-like dopamine receptors density in
the nucleus accumbens (Puglisi-Allegra and Cabib 1997)
might allow a higher proportion of the receptors to be
activated more quickly in DBA/2 mice. Secondly,
enhanced dopamine release in the medial prefrontal
cortex (Ventura et al. 2004) and a higher number of
D2-like receptors in the ventral tegmental area and
substantia nigra, in combination with a higher dopami-
nergic autoreceptors-to-postsynaptic receptors ratio in the
striatum (Puglisi-Allegra and Cabib 1997), might all
contribute to facilitate the inhibition of mesolimbic dopa-
minergic hyperactivity induced by amphetamine (Zocchi
et al. 1998).
In response to PCP, both mouse strains showed an
increase in activity to a similar absolute magnitude within
the first bin (Fig. 5c), which is in contrast to the initial
impact of amphetamine challenge such that the baseline
strain difference persisted in the first two bins post-injection
(Fig. 5b). Subsequently, the activity level in the PCP-treated
C57BL/6 mice gradually returned to that of vehicle-treated
C57BL/6 mice. In contrast, the cessation of the motor
response to PCP challenge was less rapid in the DBA/2
mice and still had not returned to control levels by the
session’s end. Hence, even if one argues that their initial
response was weaker than C57BL/6 mice in terms of
proportional elevation of activity level relative to vehicle
treatment, the interpretation that their response was pro-
tracted in time remains non-negotiable. One way to
overcome the confounding difference in baseline activity
difference (pre-drug phase in a within-subject design or
vehicle treatment as in a between-subject design adopted
here) is to use a subtraction scoring method. Based on this,
Alexander et al. (1996) concluded that DBA/2 and C57BL/
6 mice do not differ in their overall response to PCP,
although they did not provide a temporal profile analysis.
Given that current data on this issue are scant, further
investigations are certainly warranted.
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The absence of concurrent neurochemical measures in
the present study, however, precludes an extended discus-
sion of the possible differences in neurotransmitter func-
tions between DBA/2 and C57BL/6 mice. Nonetheless, the
evidence here is suggestive of differences between these
two mouse strains in both dopaminergic and glutamatergic
functions, including perhaps their interaction. It remains to
be determined whether these neuropharmacological differ-
ences may underlie some of the key behavioural and
cognitive divergence between them.
A postscript on the caveats in strain comparison studies
Whilst strain comparison between inbred strains of labora-
tory rodents can be a fruitful approach in behavioural
genetics, the present study also illustrates that care and
caution must be exercised in the interpretation of the data
because it is often the case that different strains are
associated with multiple behavioural differences. These
can be significant confounding variables in one particular
experiment, yet not in another. The present study was
motivated first and foremost by the need to address the
significant confounding changes in startle reactivity and
their possible impact on interpreting PPI data. This was
explicitly addressed here for the first time and was resolved
using a novel paradigm designed particularly for dealing
with such a confound. In addition, critical confounding
changes were also recognised in all subsequent tests
conducted. In the assessment of LI, the results were
confounded by strain difference in avoidance learning as
such, which in turn was confounded by differences in the
frequency of spontaneous shuttle responses. In both experi-
ments (experiments 3A and 3B), appreciation of these
confounds have enriched rather than limited our interpre-
tation of the data. In evaluating the motor stimulating effect
of psychomimetic drugs, interpretation of the data derived
from the drugged groups was confounded by baseline strain
difference in the vehicle treatment condition. This, howev-
er, cannot be easily overcome, except by the use of a
within-subject design in combination with prolonged
apparatus habituation to minimise or eliminate such
baseline differences.
Conclusion
There is a strong genetic component to schizophrenia, and
therefore, comparative studies of inbred laboratory rodents
offer an opportunity to identify the genetic and associated
physiological mechanisms that may underlie selected
endophenotypes of the disease. The comparison between
DBA/2 and C57BL/6 mice may represent a promising
comparative couple perhaps in the search of potential
candidate genes, neural mechanisms and neurodevelopmen-
tal divergences that may underlie the pathophysiology of
multiple schizophrenia-related endophenotypes. It is a
welcomed addition to the bottom-up approach of point
mutation generated by genetic engineering. However,
unlike treatment-based disease models, such as mutations,
drugs or specific neurodevelopmental interference, the
precise cause and effect relationship underlying strain
differences is particularly difficult to pin down because
the mouse strains are “given to” rather than “by design of”
the experimenter. To harness the power of such mouse
strain models, testable hypotheses targeting individual
phenotypic components ought to be thoroughly evaluated
by other experimental approaches.
Lastly, it is essential to recognise that comparative
analysis of behavioural phenotypes between strains is
necessarily relative in nature and is heavily influenced by
the choice of the control or reference strain. The behav-
ioural deficiencies in the DBA/2 mice revealed here are all
based on a unique comparison with the C57BL/6 strain, and
it is not at all difficult to conceive that a very different
picture may emerge if another reference strain were
employed. It would be inappropriate to refer to the
DBA/2 mouse strain as a “psychotic” mouse strain in
absolute terms. In contrast, schizophrenia is recognised as a
disease entity in the clinic, and the diagnostic criteria are
designed to minimise such arbitrary relativism. Relatively
speaking, the DBA/2 strain may be associated with a
propensity to develop behavioural traits that may resemble
those of schizophrenia, but this does not imply that these
mice are suffering from psychosis.
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